Sacyr, S.A.

BME:SCYR Lagerbericht

Marktkapitalisierung: €2.4b

Sacyr Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Sacyr wird ein jährliches Gewinn- und Umsatzwachstum von 48.3% bzw. 2% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 56% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.2% betragen.

Wichtige Informationen

48.3%

Wachstumsrate der Gewinne

56.0%

EPS-Wachstumsrate

Construction Gewinnwachstum5.2%
Wachstumsrate der Einnahmen2.0%
Zukünftige Eigenkapitalrendite12.2%
Analystenabdeckung

Good

Zuletzt aktualisiert31 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 10
Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Recent updates

Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

Sep 10
Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

Jun 06
Sacyr, S.A.'s (BME:SCYR) Business Is Yet to Catch Up With Its Share Price

Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

Apr 18
Sacyr (BME:SCYR) Use Of Debt Could Be Considered Risky

Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

Mar 06
Is There Now An Opportunity In Sacyr, S.A. (BME:SCYR)?

What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Sep 08
What Does Sacyr, S.A.'s (BME:SCYR) Share Price Indicate?

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Aug 18
Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

May 11
Sacyr (BME:SCYR) Takes On Some Risk With Its Use Of Debt

Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

Mar 22
Is It Too Late To Consider Buying Sacyr, S.A. (BME:SCYR)?

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Feb 10
Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

Dec 01
Is Sacyr, S.A. (BME:SCYR) Trading At A 29% Discount?

Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Nov 10
Sacyr, S.A. (BME:SCYR) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Aug 02
Sacyr (BME:SCYR) Has A Somewhat Strained Balance Sheet

Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Jun 02
Sacyr's (BME:SCYR) Upcoming Dividend Will Be Larger Than Last Year's

Is Sacyr (BME:SCYR) A Risky Investment?

Oct 19
Is Sacyr (BME:SCYR) A Risky Investment?

Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Jul 14
Does Sacyr (BME:SCYR) Have A Healthy Balance Sheet?

Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

Mar 06
Robust Earnings May Not Tell The Whole Story For Sacyr (BME:SCYR)

An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

Feb 19
An Intrinsic Calculation For Sacyr, S.A. (BME:SCYR) Suggests It's 41% Undervalued

How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

Jan 20
How Many Sacyr, S.A. (BME:SCYR) Shares Do Institutions Own?

Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

Dec 24
Have Insiders Been Selling Sacyr, S.A. (BME:SCYR) Shares?

What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 02
What Type Of Returns Would Sacyr's(BME:SCYR) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Gewinn- und Umsatzwachstumsprognosen

BME:SCYR - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (EUR Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20264,727207-2281,3408
12/31/20254,595191-4771,2319
12/31/20244,430160-6901,0609
6/30/20244,569-1738311,061N/A
3/31/20244,565-156N/AN/AN/A
12/31/20234,621-158624848N/A
9/30/20235,647135N/AN/AN/A
6/30/20234,981122669806N/A
3/31/20235,956121N/AN/AN/A
12/31/20224,985102121705N/A
9/30/20225,478-182N/AN/AN/A
6/30/20224,706-183-45606N/A
3/31/20224,835-194N/AN/AN/A
12/31/20214,696-189428629N/A
9/30/20214,65549N/AN/AN/A
6/30/20214,6346478609N/A
3/31/20214,62029N/AN/AN/A
12/31/20204,54936410545N/A
9/30/20204,349-373N/AN/AN/A
6/30/20204,241-308377552N/A
3/31/20204,191-304N/AN/AN/A
12/31/20194,178-298307510N/A
9/30/20194,148164N/AN/AN/A
6/30/20194,031158221453N/A
3/31/20193,903154N/AN/AN/A
12/31/20183,818150234405N/A
9/30/20183,548143N/AN/AN/A
6/30/20183,375143166290N/A
3/31/20183,196134N/AN/AN/A
12/31/20173,094131N/A292N/A
9/30/20172,949127N/AN/AN/A
6/30/20172,970116N/A288N/A
3/31/20172,968109N/AN/AN/A
12/31/20162,862120N/A156N/A
9/30/20162,991-53N/AN/AN/A
6/30/20163,028-782N/A71N/A
3/31/20162,976-784N/AN/AN/A
12/31/20152,953-813N/A160N/A
9/30/20153,007-737N/AN/AN/A
6/30/20152,890-31N/A253N/A
3/31/20152,793-36N/AN/AN/A
12/31/20142,726-10N/A43N/A
9/30/20142,489-370N/AN/AN/A
6/30/20142,497-352N/A83N/A
3/31/20142,596-308N/AN/AN/A
12/31/20132,675-310N/A207N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SCYR wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (1.7%).

Ertrag vs. Markt: SCYR wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: SCYR wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: SCYRDie Einnahmen des Unternehmens (2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt Spanish (5% pro Jahr).

Hohe Wachstumseinnahmen: SCYRDie Einnahmen des Unternehmens (2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SCYRDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.2%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y